Publications

Stefater-Richards MA, Jhe G, Zhang YJ. “GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity.” Pediatrics, April 2025.

Stefater-Richards MA, Panciotti C, Esteva V, Lerner M, Petty CR, Gourash WF, Courcoulas AP. Gastric Bypass Elicits Persistent Gut Adaptation and Unique Diabetes Remission-Related Metabolic Gene Regulation. Obesity, October 2024; 1-14.

Philpott JD, Marco Rodriguez Hovnanian K, Stefater-Richards MA, Mehta N, Martinez E. The Enteroendocrine Axis and Its Effect on Gastrointestinal Function, Nutrition and Inflammation. Curr Opin Crit Care, August 2024; 30(4): 290-297.

Stefater-Richards MA, Panciotti C, Feldman H, Gourash W, Shirley E, Hutchinson JN, Golick L, Park SW, Courcoulas AP, Stylopoulos N. Jejunal Adaptation After Gastric Bypass in Humans Reveals Metabolically Significant Shift in Fuel Metabolism. Obesity, January 2023; 31(1): 49-61.

Stefater MA, Marks BE. Gastric Bypass in an Adolescent with Obesity, Insulin Resistance, and Type 1 Diabetes. Obesity Surgery, May 2021; 31(5): 2298-2301.

Saeidi N, Stefater M, Stylopoulos N. [Comment On] Effect of Diet versus Gastric Bypass on Metabolic Function in Diabetes. New England Journal of Medicine, December 2020; 383(24):2391-2392.

Abidi W, Nestoridi E, Feldman H, Stefater MA, Clish C, Thompson C, Stylopoulos N. Differential Metabolomic Signatures in Patients with Weight Regain and Sustained Weight Loss after Gastric Bypass Surgery: A Pilot Study. Digestive Diseases and Sciences, August 2020; 65(4): 1144-1154.

Stefater MA, Pacheco JA, Bullock K, Pierce K, Deik A, Liu E, Clish C, Stylopoulos N. Portal Venous Metabolite Profiling After RYGB in Male Rats Highlights Changes in Gut-Liver Axis. Journal of the Endocrine Society, January 2020; 4(2): bvaa003.

Courcoulas AP, Stefater MA, Shirley E, Gourash WF, Stylopoulos N.  The Feasibility of Examining the Effects of Gastric Bypass Surgery on Intestinal Metabolism: Prospective, Longitudinal Mechanistic Clinical Trial.  JMIR Res Protoc, January 2019; 8(1):e12459.

Tao R, Wang C, Stohr O, Qiu W, Hu Y, Miao J, Dong XC, Leng S, Stefater M, Stylopoulos N, Lin L, Copps KD, White MF.  Inactivating hepatic follistatin alleviates hyperglycemia.  Nature Medicine, June 2018; 24(7): 1058-1069.